Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Steroid Biochemistry and Molecular Biology|April 11, 2024
Structural mechanism underlying variations in DNA binding by the androgen receptorXiao Yin Lee, Wout Van Eynde, Christine Helsen, et al.
European Journal of Medicinal Chemistry|June 5, 2025
Investigating the structure-activity-relationship of diaryl ether-based paFabV inhibitors: A path to novel antibacterialsRadu-George Bulai, Wout Van Eynde, Sofie Heylen, et al.
European Journal of Medicinal Chemistry|October 20, 2024
Synthesis of 3-heteroaryl-pyrrolo[2,3-b]pyridines as potent inhibitors of AP-2-associated protein kinase 1 (AAK1) with antiviral activityNitha Panikkassery Ravi, Wout Van Eynde, Marwah Karim, et al.
European Journal of Medicinal Chemistry|August 13, 2025
Discovery of antivirally active inhibitors of adaptor protein-2 associated kinase 1 based on various bicyclic heteroaromatic scaffolds derived from a 7-azaindole analogueStijn Anthonissen, Wout Van Eynde, Marwah Karim, et al.
ACS Synthetic Biology|May 10, 2025
Rewiring Estrogen Receptor α into Bisphenol Selective Receptors Using Darwin Assembly-Based Directed Evolution (DADE) in Saccharomyces cerevisiaeRoy Eerlings, Xiao Yin Lee, Wout Van Eynde, et al.
European Journal of Medicinal Chemistry|June 16, 2026
Discovery of 1-(3-phenoxybenzyl)-4-(1-phenyl-1H-1,2,3-triazol-4-yl)piperidine analogues as potent and selective agonists of the human CC chemokine receptor 8Qifei Li, Wout Van Eynde, Tom Van Loy, et al.
The Journal of Experimental Medicine|August 27, 2025
Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriersMarjon Wouters, Lisa Ehlers, Wout Van Eynde, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriersMarjon Wouters, Lisa Ehlers, Wout Van Eynde, et al.
Pageof 1